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Combined endovascular and surgical approach
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William Quinones-Baldrich, MD, Juan Carlos Jimenez, MD, Brian DeRubertis, MD, and
Wesley S. Moore, MD, Los Angeles, Calif
Objective: The first combined endovascular and surgical approach for thoracoabdominal aortic aneurysm was performed
at our institution in 1998. We report a 10-year experience with a hybrid approach to thoracoabdominal aortic pathology.
Methods: Records of all patients undergoing a combined endovascular and surgical approach to thoracoabdominal aortic
pathology were reviewed. Presenting symptoms, perioperative morbidity and mortality, sequence (single versus two
stages), and late results were analyzed.
Results: From 1998 to 2008, 20 patients were treated with hybrid repairs for thoracoabdominal aneurysm (TAA) (15;
four with dissection), aortic arch aneurysm (two), symptomatic supravisceral abdominal aortic aneurysm (one), contained
perirenal pseudoaneurysm rupture (one), and floating aortic arch thrombus with cerebral and renal emboli in one patient.
Ten patients had prior aortic grafting, one patient had a functional renal transplant, and all patients were considered high
risk based on preoperative comorbidities. Aneurysm related pain (11) or aneurysm growth (eight), mesenteric ischemic
symptoms (four), and peripheral embolization (one) were indications for intervention. Spinal catheter drainage was used
routinely. The procedure was completed in a single stage (13), or two stages using a subcutaneous conduit constructed
at the first stage (six). One patient refused the second stage and expired from aneurysm rupture five months later. There
were nine major complications in six patients (32% morbidity); all recovered except one patient with complete aortic
coverage from left subclavian to bifurcation in the single stage group who developed paraplegia (one of 15 patients at risk;
6.6%). There was no perioperative mortality (0-30 days or discharge). Two patients had successful re-intervention for a
type I (included as a major complication) and II endoleak respectively. Two type II endoleaks without aneurysm growth
continue under observation. There has been no graft thrombosis, aneurysm growth, or rupture during a mean follow-up
of 16.6 months (range, 1-119 months) in 19 patients with a completed procedure (none lost to follow up). Cumulative
survival at two years is 76%.
Conclusions: A combined endovascular and surgical approach to thoracoabdominal aortic pathology can be performed in
high-risk patients with acceptable morbidity and mortality. A two-stage approach is preferable when extensive coverage
of the aorta is necessary and a subcutaneous conduit simplifies the second stage. Follow-up of 10 years in our initial
patient suggests that this approach can be durable. Additional experience and longer follow-up is needed before
expanding current indications for this approach. (J Vasc Surg 2009;49:1125-34.)Endovascular aortic grafting has become an excellent
alternative for management of patients with abdominal
aortic aneurysms or descending thoracic aneurysms partic-
ularly when significant comorbidities are present.1 Endo-
vascular repair of suitable aortic aneurysms have resulted in
decreased morbidity and mortality. Open surgical repair of
these pathologies is now usually reserved for younger good
risk patients or patients with unsuitable anatomy for an
endovascular approach. Continued evolution of endovas-
cular technology is likely to improve results and address
some of the anatomic limitations that currently exist.
Patients with thoracoabdominal aortic pathology with
involvement of arch or visceral vessels represent a particular
challenge for endovascular repair. Efforts in developing
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doi:10.1016/j.jvs.2008.12.003branch endografts are underway and have seen some suc-
cess in a very limited experience.2 Combining established
surgical techniques with endovascular grafting is another
alternative in the management of patients with arch or
visceral involvement who currently are not candidates for a
complete endovascular approach. These patients frequently
have significant comorbidities and can benefit from a lesser
procedure using a combined technique.
In 1998, we evaluated a patient who had suffered two
infrarenal abdominal aortic aneurysm ruptures, each
treated successfully using a transabdominal and a retroper-
itoneal approach respectively. He presented with a type IV
thoracoabdominal aneurysm and aneurysms of both renal
arteries, the celiac artery, and the superior mesenteric ar-
tery. Using a combined endovascular and surgical approach
(CESA), the type IV thoracoabdominal aneurysm and the
visceral aneurysms were repaired by retrograde revascular-
ization of the visceral vessels with individual grafts, and
exclusion of the thoracoabdominal aneurysm using an en-
dovascular graft.3 Concerns about the durability of this
approach made us hesitant to recommend it to other pa-
tients with thoracoabdominal aneurysms. After a four-year
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considering CESA for high-risk patients with arch and
thoracoabdominal aneurysms.
This report summarizes our experience and the lessons
learned with a combined endovascular and surgical (hy-
brid) approach in the management of high-risk patients
with thoracoabdominal aortic pathology.
PATIENTS AND METHODS
Using a prospectively maintained database, the records
of all patients undergoing a combined endovascular and
surgical approach for repair of thoracoabdominal aortic
pathology at the UCLA Medical Center were reviewed.
Age at presentation, gender, indication for repair, type of
aneurysm (if present), and comorbidities (coronary artery
diseasewithorwithout priormyocardial infarction, congestive
heart failure, hypertension, renal function, diabetes mellitus,
smoking history, pulmonary disease, or other systemic con-
dition) were recorded. American Society of Anesthesiolo-
gists (ASA) classification was determined based on these
comorbidities. When the patient had four or more of these
risk factors, ASA class 4 was assigned. Patients in ASA class
2 had at least two of these conditions.
Symptoms related to the presenting aneurysm, isch-
emic symptoms from branches arising from the affected
segment, history of aortic surgery, and the presence of
aortic dissection were noted. Details of the procedure were
recorded. Specifically, whether the approach was a single or
a two-stage procedure, use of spinal catheter drainage,
specific branches revascularized, proximal and distal land-
ing zones for the endografts, and number of endografts
used, were recorded. Operative time, intraoperative blood
loss, and total contrast used was noted.
The in-hospital postoperative course was reviewed not-
ing intensive care unit (ICU) stay, and complications such
as graft thrombosis, myocardial infarction, postoperative
renal insufficiency, pulmonary complications, bleeding, in-
fection, and reoperation. Postoperative mortality was de-
fined as death within the hospital stay of the procedure, or
within 30 days of operation. Postoperative renal insuffi-
ciency was considered significant when more than a 50%
rise of preoperative creatinine was noted or if the patient
required dialysis at any point during the postoperative
course. Pulmonary complications were considered signifi-
cant if the patient required respiratory assistance for longer
than 72 hours after surgery, or reintubation. Postoperative
bleeding was considered significant if reoperation for
bleeding was necessary. Infection was considered signifi-
cant if it prolonged hospital stay or required any additional
intervention or readmission.
Long-term results were based on clinic notes during
follow-up, surveillance computed tomography (CT) scans,
hospital records if readmission occurred, and patient inter-
view by telephone when no additional information within
three months was available at the time of this review.
Specifically, any complications related to the retrograde or
extra-anatomic grafts were noted. The presence or absence
of endoleak of any type was recorded. Aneurysm size basedon surveillance CT scans and any type of reintervention
related to the procedure were noted. Survival was calcu-
lated using actuarial methods.
RESULTS
Between October of 1998 and September of 2008, 20
patients presenting with thoracoabdominal aneurysm, aor-
tic arch aneurysms or other aortic process, and significant
increased risk for conventional repair due to comorbidities
and/or prior aortic surgery were treated with a combined
endovascular and surgical repair of their pathology. Patient
demographics and co-morbidities including ASA classifica-
tion is presented in Table I. Their age ranged from 51 to 89
years with a mean age of 68 years. There were 11 males and
9 females. There were 12 patients with history of coronary
artery disease; eight had a myocardial infarction in the past.
Two of these patients had chronic congestive heart failure.
Most patients (18 of 20) had history of hypertension and in
five, it was poorly controlled on multiple medications.
Significant chronic obstructive pulmonary disease was
present in 12 patients, including one patient who was
oxygen dependent. Four patients had diabetes mellitus,
including one patient on chronic hemodialysis. Renal insuf-
ficiency, with creatinine greater than 1.5, was present in
three patients. Three patients had suffered hemispheric
strokes including one patient with an acute stroke, which
Table 1. Demographics and risk factors in 20 patients
treated with combined endovascular and surgical
approach (CESA) for thoraco-abdominal aortic pathology
Demographics and risk factors Number (%)
Age 51-89 years (mean, 68 years)
Male/female 11 (55%)/9 (45%)
CAD/MI 12 (60%)/8 (40%)
CHF 2 (10%)
HTN/poor control 18 (90%)/5 (25%)
COPD 12 (60%)
CRF/CRI 1 (5%)/3 (15%)
Stroke/Acute 3 (15%)/1 (5%)
CMI 4 (20%)
SLE 2 (10%)
Hyperthyroidism 1 (5%)
ASA Class 3 10 (50%)
ASA Class 4 7 (35%)
Symptomatic 13 (65%)
TAA 15 (75%)
Type II 3 (20%)
Type III 8 (53%)
Type IV 4 (27%)
Dissection 4 (27%)
Other aortic pathology 5 (25%) see text
Major surgery 14 (70%)
Aortic 12 (60%)
Other (see text) 2 (10%)
ASA, American Society of Anesthesiologists; CAD, coronary artery disease;
CHF, congestive heart failure; CMI, chronic mesenteric ischemia; COPD,
chronic obstructive pulmonary disease; CRF/CRI, chronic renal failure/
insufficiency; HTN, hypertension; MI, myocardial infarction; SLE, systemic
lupus; TAA, thoraco-abdominal aneurysm.represented the indication for intervention. Four patients
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mented stenosis or occlusion of at least two mesenteric
vessels. Two patients had systemic lupus, and one patient
was hyperthyroid, controlled during the same admission.
Seventeen patients were ASA class 3 (10) or 4 (7).
Indications for intervention and procedure details are
summarized in Tables II and III. Three patients were ASA
class 2 and presented significant risk owing to prior aortic
surgery (thoracic interposition graft with left heart bypass
for acute type B dissection; arch replacement with elephant
trunk and AAA repair) or abdominal surgery (gastrectomy
and gastrojejunostomy). Two patients presented with large
aortic arch aneurysms, and one patient had an exophitic
ulcerated plaque with floating thrombus in the transverse
aortic arch and emboli to the brain and kidney. Fifteen
patients had thoracoabdominal aneurysms. There were
three type II, eight type III (including one patient with a
ruptured visceral patch after previous surgical repair), and
four type IV thoracoabdominal aneurysms. Four of these
patients had chronic aortic dissection. One patient had a
ruptured juxtarenal aneurysm after a prior infrarenal aortic
repair, and one patient had a perivisceral aneurysm with
chronic mesenteric ischemia.
There were 13 symptomatic and seven asymptomatic
patients. Symptomatic patients included four patients who
presented with chronic mesenteric ischemic symptoms.
One patient had a functioning renal transplant and one
patient was on chronic hemodialysis. One patient (#20)
presented with an acute left hemispheric stroke, left internal
carotid and left subclavian artery occlusion, and a renal
infarct. CT scan and transesophageal echo showed exo-
phitic plaques with floating thrombi in the aortic arch and
descending thoracic aorta. Aneurysm size varied from 5 cm
to 9.3 cm with an average of 6.9 cm. Twelve patients had
prior major abdominal or thoracic surgery including 10
patients with prior aortic aneurysm repair, one patient with
a renal transplant, and one with a partial gastrectomy and
gastrojejunostomy. One patient had a type A dissection
repair, and one patient with a type II thoracoabdominal
aortic aneurysm with dissection had a prior interposition
graft in the proximal descending thoracic aorta via a left
thoracotomy with left heart bypass.
All patients except those with arch aneurysm repairs
had spinal catheter drainage during the endovascular por-
tion of the procedure. Thirteen patients were treated in one
stage including the three patients with arch pathology.
Seven patients were treated in two stages. All two stage
procedures were preplanned based on the anticipated ex-
tensive coverage of the thoracoabdominal aorta. One pa-
tient, intended to be treated in two stages, refused the
second stage (89 years old) and ruptured the aneurysm five
months after the first stage. This patient is included in this
series for analysis on intent to treat basis. Trans-esophageal
echocardiography was used in three of four patients with
chronic aortic dissection and found to be useful in determin-
ing guide-wire location in either the true or false lumen. In
one of these patients (with prior thoracic interposition graft),the endografts were purposely deployed in the false lumen to
allow maximum endograft expansion (Fig 1).
Operating time averaged 8.4 hours for patients done in
one stage and 8.3 hours for the first stage of patients treated
in two stages. The endovascular stage of the procedure in
the two-stage group took an average of two hours. The
average number of devices used for the endovascular por-
tion of the procedure was 2.8 devices. Estimated blood loss
for patients treated in one stage and for the first stage of
patients treated in two sessions was 920mL. For the second
stage of the procedure, the average blood loss was 400 mL.
Average contrast used for the endovascular portion of the
procedure in all cases was 254 mL (100-434 mL). When
marker clips were used to fluoroscopically identify the
origin of the retrograde or antegrade grafts, less contrast
was used (160 mL vs 331 mL) All patients treated in two
stages had a subcutaneous conduit placed at the first stage
of the procedure and successfully used for the placement of
the endovascular devices during the second stage. Marker
clips placed proximal to the origin of the retrograde by-
passes were found to be extremely useful during the second
stage of the procedure reducing the amount of contrast
necessary for accurate deployment (Fig 2). One patient on
hemodialysis had revascularization of only the superior
mesenteric and the celiac artery with left nephrectomy
using a left retroperitoneal approach.
Complications included paraplegia in one patient (sin-
gle stage group) who had coverage from the left common
carotid to the right iliac bifurcation using thoracic en-
dografts and a bifurcated AAA endograft. Retrograde re-
vascularization to the SMA and celiac artery originated
from a graft used to repair a common iliac artery aneurysm.
No renal bypasses were necessary as the patient was on
chronic hemodialysis. This patient became paraplegic 24
hours after the procedure during an episode of hypotension
(1/15 patients at risk; 6.6% overall risk of paraplegia). In
retrospect, this patient could have been treated in two
stages, given the extensive aortic coverage necessary. Dete-
rioration of renal function occurred in one patient with a
preoperative creatinine of 2.2 rising to 3.6 after a one-stage
procedure, who recovered without need for dialysis. One
patient suffered a minor myocardial infarction without
sequela and respiratory failure requiring re-intubation oc-
curred in three patients. One patient had prolonged respi-
ratory failure after requiring reoperation within 24 hours
for a second look laparotomy and repair of an enterotomy.
This patient survived the procedure but was in the intensive
care unit for 92 days. Average ICU stay was 9.4 days.
Excluding this patient, average stay in the intensive care
unit was 4.8 days. There were no strokes associated with the
procedures in either the single or two-stage group. Chylous
ascites developed in the patient with prolonged respiratory
failure and eventually responded to conservative measures.
Excluding patients in the two-stage approach, three
patients were readmitted within 30 days of discharge. One
patient was readmitted for a repair of a distal type I en-
doleak, which was resolved with an additional thoracic
endograft. The remaining two patients were readmitted for
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Patient
Age
(years) Indication
ASA
class
Debranching
details
Endograft
proximal
landing zone
Endograft distal
landing zone
Perioperative
complication
(30 days)
Follow up
(months)
1 62 5 cm Type IV
TAA
2 Right iliac-celiac-
SMA bypass;
right ileo-
birenal bypass
Descending thoracic
aorta
Prior infrarenal
aortic graft
None 119
2 63 6.7 cm Type III
TAA
4 Right iliac-celiac-
SMA bypass;
right iliac to
left renal bypass
Descending thoracic
aorta
Prior infrarenal
aortic graft
None 33
3 86 Contained
rupture of
visceral patch
12 years after
repair of
ruptured type
III TAA
3 Retrograde aorto-
celiac-SMA
bypass,
retrograde
aorto-bi-renal
bypass
Descending thoracic
aortic graft
Infra-renal
portion of
prior aortic
graft
None 31
4 70 5.7 cm Type II
TAA
3 Retrograde
Aorto-celiac-
SMA-bi-renal
bypass
Descending thoracic
aorta
Distal infrarenal
aorta
None 24
8 51 11 cm aortic arch
and
descending
thoracic
aneurysm with
type B
dissection
3 Aorto-innominate
and aorto-left
common
carotid artery
bypass; left
carotid
subclavian
bypass, coil
embolization of
left subclavian
artery
Proximal aortic arch Supraceliac
aorta
Reintervention on
postoperative
day 8 for large
type I distal
endoleak
resolved with
additional
endograft
14
9 71 7.0 cm
perivisceral
aneurysm
3 Left iliac-celiac-
SMA bypass.
(Renal
transplant right
iliac artery)
Descending thoracic
aorta
Main body of
prior
infrarenal
endograft
None 13
12 67 7 cm Type III
TAA, critical
stenosis of
celiac trunk
and SMA
4 Left iliac-celiac-
SMA bypass
Descending thoracic
aorta
Juxtarenal aorta Bilateral lower
extremity
paraplegia
developed on
postoperative
day 1
6 Death due
to MI
14 75 8.5 cm Type IV
AAA with
critical stenosis
of celiac trunk
and SMA,
large distal
aortic pseudo
aneurysm
3 Resection of prior
disrupted aortic
tube graft,
placement of
aortobi-iliac
bypass graft,
retrograde
aorto-celiac-
SMA bypass,
retrograde
aorto-bi-renal
bypass
Descending thoracic
aorta
Distal main
body of
aortic
bifurcation
graft
Respiratory failure
requiring
prolonged
ventilator
dependence,
chylous ascites
6 Death due
to
respiratory
failure
and CHF
15 76 6.5 cm Type III
TAA
4 Retrograde aorto-
celiac-SMA
bypass,
retrograde
aorto-bi-renal
Descending thoracic
aorta
Infrarenal aorta None 7bypass
gists; C
rysm.
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rotomy and lysis of adhesions. All three patients recovered
without further complication. There was no mortality prior
to hospital discharge or within 30 days of the completed
procedure associated with the combined endovascular and
surgical approach in these high-risk patients.
All patients have been followed at the UCLA Medical
Center with either CT scan or magnetic resonance (MR)
imaging at regular intervals. No patient has been lost to
follow-up and all surviving patients were assessed within
three months of this report. There have been three type II
endoleaks and one type I endoleak requiring intervention
as stated above. One type II endoleak occurred from a
partially ligated celiac artery and was treated by placement
of a covered stent through the retrograde bypass excluding
flow to the splenic artery. Two type II endoleaks secondary
to small lumbar arteries remain under observation without
evidence of aneurysm growth.
Follow-up ranges from 1-120 months with a mean
follow-up of 16.6 months. There have been five deaths
during follow-up in this series. One was a patient who
completed the first stage, refused to have the second stage,
and had aneurysm rupture and death. Four additional
patients died all within the first six months of the completed
procedure. One patient had suffered prolonged respiratory
Table II. Continued.
Patient
Age
(years) Indication
ASA
class
Debranching
details
16 73 9.5 cm juxtarenal
aortic pseudo
aneurysm
4 Left supraceliac to
left renal artery
bypass, right
common iliac
to right renal
artery bypass
Ju
17 74 6.3 cm Type I
TAA with
Type B
dissection, 3.8
cm right
common iliac
aneurysm
3 Right iliac-celiac-
SMA bypass,
resection of
right common
iliac aneurysm
and repair with
interposition
Dacron graft
De
19 76 5.2 cm
perivisceral
aneurysm with
SMA, celiac
stenosis
3 Retrograde right
common iliac-
celiac-SMA and
bi-renal bypass
De
20 67 Aortic arch
plaques and
floating
thrombus with
emboli to left
ICA, occlusion
left subclavian
artery and
renal infarct
3 Left carotid-
subclavian
bypass;
Ascending
aorta to
innominate and
left carotid
bypass
As
AAA, Abdominal aortic aneurysm; ASA, american Society of Anesthesiolo
infarction; SMA, superior mesenteric artery; TAA, thoraco-abdominal aneufailure and was recovering in a nursing home at the time ofdeath. Two patients died of congestive heart failure or
myocardial infarction at five and six months respectively
after surgery. One patient died of an unrelated cause (no
evidence of aneurysm rupture) at six months. There has
been no bypass thrombosis or aneurysm growth or rupture
in the 19 patients with a completed repair. Cumulative
survival by actuarial methods is 71.1% at two years when all
patients are included (intent to treat). In patients complet-
ing the procedure, cumulative survival at two years is
76.5%.
DISCUSSION
In 1998, we evaluated a patient presenting with a type
IV thoracoabdominal aneurysm and aneurysms of all vis-
ceral vessels. He had history of two infrarenal aneurysm
ruptures repaired using a transabdominal and a retroperi-
toneal approach, respectively. A combined endovascular
and surgical approach was used for treatment of his thora-
coabdominal aneurysm.3 This was proposed in order to
minimize the risks of conventional surgery in that particular
case. We were reluctant to recommend CESA to patients
with thoracoabdominal aortic pathology owing to our con-
cerns about the durability and effectiveness of this hybrid
procedure. After a four-year follow-up of our initial patient,
and noting his excellent clinical course, we began consid-
dograft
oximal
ing zone
Endograft distal
landing zone
Perioperative
complication
(30 days)
Follow up
(months)
al aorta Prior infrarenal
aortic graft
Transient rise in
creatinine (3.6)
No dialysis
5 Death due
to CHF
ing thoracic Suprarenal aorta None 4
ing thoracic Infra-renal
aortic graft
None 1
ng aorta Descending
thoracic aorta
None 1
HF, congestive heart failure; ICA, internal carotid artery; MI, myocardialEn
pr
land
xtaren
scend
aorta
scend
aorta
cendiering CESA for high-risk patients presenting with thoraco-
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Patient
Age
(years) Indication
ASA
class Debranching details
Endograft
proximal landing
zone
Endograft distal
landing zone
Perioperative
complication
(30 days)
Follow up
(months)
5 68 6.7 cm Type
III TAA
3 Resection of infrarenal
AAA, placement of
aortobi-iliac bypass
graft, Right iliac-
celiac-SMA bypass;
right ileo-birenal
bypass
Descending
thoracic aorta
Distal infrarenal
aortic graft
Small bowel
obstruction
requiring
laparotomy;
respiratory failure
requiring
reintubation
20
6 75 5 cm
perivisceral
AAA with
symptomatic
SMA
stenosis
3 Right iliac-celiac-SMA
bypass; right ileo-
birenal bypass
Descending
thoracic aorta
Prior infrarenal
aortic graft
None 16
7 60 Type A  B
aortic
dissection
with
multiple
aneurysmal
aortic
segments;
maximal
diameter 6.1
cm
2 Left iliac-celiac-SMA
bypass; left ileo-
birenal bypass
Descending
thoracic aorta
Prior infrarenal
aortic graft
None 6 Death –
cause
unknown
No
evidence
of TAA
rupture
10 89 7.1 cm Type
III TAA,
occlusion of
celiac trunk
and SMA,
right
common
iliac
aneurysm
3 Resection of infrarenal
AAA; Placement of
aortobi-iliac bypass
graft, Right iliac-
celiac-SMA bypass;
right iliac-bi-renal
bypass
N/A N/A None (Stage 1 only) 5 Death
5 mo
after
stage 1;
stage 2
not done
11 59 7 cm aortic
arch and
descending
thoracic
aneurysm,
infrarenal
AAA, type B
dissection
4 Right common
carotid to left
subclavian bypass;
Division left CCA
with proximal
ligation and
implantation to side
of carotid to
subclavian bypass
Aortic arch
between
innominate and
left common
carotid artery
Distal infrarenal
aortic graft
Segmental iliac
resection for
intraoperative
enterotomy
during
debranching
procedure
11
Resection of infrarenal
AAA, right iliac-
celiac-SMA bypass,
right ileo-birenal
bypass
13 51 6.0 cm Type
III TAA
with type B
dissection
2 Resection of infrarenal
aorta, placement of
aortic tube graft,
retrograde aorto-
celiac-SMA bypass,
retrograde aorto-bi-
renal bypass, aorto-
lumbar bypass
Descending
thoracic aorta
Endograft placed
in false lumen
Distal prior
aortic tube
graft
*Endograft
placed in
false lumen
Small bowel
obstruction
requiring
laparotomy on
postoperative day
17
6
18 59 6.5 cm Type II
TAA
4 Retrograde aorto-celiac-
SMA-Left renal artery
bypass; right common
iliac to right renal
artery bypass
Aortic arch
proximal to left
subclavian
artery
Distal infrarenal
aorta
None 3
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiologists; CCA, common carotid artery; CHF, congestive heart failure; ICA, internal
carotid artery; MI, myocardial infarction; SMA, superior mesenteric artery; TAA, thoraco-abdominal aneurysm.
*See Figure 1.
during the first stage of the procedure.
superior mesenteric artery.
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surgery were acceptable,4 and therefore we limited CESA
for patients with significant comorbidities in whom con-
ventional surgery would represent an unacceptable risk.
Our results, to date, support using a combined approach
for patients at high risk for conventional surgery.
Since 2004, there have been several series with 10 or
more patients reported using a combined endovascular and
surgical approach to thoracoabdominal aortic pathology.
These are summarized in Table IV. In the series reported by
Lee and colleagues, the first stage of the procedure was
associated with significant morbidity and mortality (25%,
24%).5 They noted, however, that for the entire series,
there was no incidence of paraplegia. In patients complet-
ing both procedures, there were no deaths and the primary
patency for the visceral grafts was 96% at a mean follow-up
of eight months. Resch and associates reported that most of
the morbidity and mortality of the hybrid procedures for
thoracoabdominal aortic pathology in high-risk patients were
associated with those who presented with rupture.6 Black and
coworkers reported a similar experience in patients who were
operated urgently or emergently secondary to symptomatic or
ruptured aneurysms.7 Mortality for elective cases was 13%.
None of the patients treated for ruptured aneurysms with a
hybrid procedure survived. Based on this experience, the role
of a hybrid approach for treatment of ruptured thoracoab-
dominal aneurysms seems limited.
Zhou and associates treated 31 patients using a hybrid
approach for complex thoracoabdominal aneurysms in high
risk patients.8 Sixteen ascending and arch aneurysms and 15
thoracoabdominal aneurysms were successfully managed
with a mortality of 3.2% and no incidence of paraplegia or
stroke. At a mean follow-up of 16 months, there were two
patients who died of unrelated causes, but there was no
e second stage deployment of the endovascular grafts.
false lumen as identified by the transesophageal echo,
cic aortic graft, and an infrarenal aortic graft placedFig 1. A, transesophageal echocardiography used during th
B, in this particular case, the endograft was deployed in the
between the previously placed proximal descending thoraFig 2. Intraoperative picture of a first stage procedure with retrograde
grafts to both renal arteries, the superiormesenteric artery, and the celiac
artery.Note the placement of a conduit that was left in the subcutaneous
tissue and successfully used during the second stage. Marker clips are
placed to help fluoroscopically identify themost distal landing site for the
endografts during the second stage of the procedure. R, right; SMA,aneurysm enlargement and all remaining patients were
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support a hybrid approach in selected high-risk patients.
Chiesa and colleagues reported thirteen high-risk pa-
tients (all ASA class 3 or 4; all had prior aortic surgery)
treated with a single-stage hybrid repair.9 The authors
compared the results in this group with a “similar” group of
29 patients within their series of patients having surgical
treatment of thoracoabdominal aneurysms. Morbidity was
slightly higher in the surgical group (44.8%) with three
patients suffering paraplegia (10%) compared with one in
the hybrid group (7%). Mortality was higher in the hybrid
group (23% versus 17.2%), given that these patients were in
a higher risk category. The authors concluded that the
hybrid repair did not lead to significant improvement in
outcome and that further follow-up and larger series were
needed to evaluate this approach. The lower incidence of
spinal cord complications in the hybrid group however, is
encouraging. Given higher comorbidities in the hybrid
group, these results suggest that a combined endovascular
and surgical approach should be considered in selected
patients.
Bockler and colleagues recently reported their experi-
ence on 28 patients treated with a hybrid approach for
thoracoabdominal aortic aneurysm.10 There were seven pa-
tients with concomitant aortic dissection. Elective mortality
was 14.3% with an overall morbidity of 59%. Three patients
suffered paraplegia. Graft patency at mean follow-up of 13
months was 86% and they found no significant difference
between patients approached in a single stage and those
undergoing a two-stage procedure. There was a significant
difference in mortality noted between cases done on an
emergency basis (28%) and those done on an elective basis
(12%). Overall survival at three years was 70%. The authors
were encouraged by their results and continue to recom-
mend a hybrid approach for high-risk patients.
Given these mixed results reported in the literature, the
role of a combined endovascular and surgical approach to
thoracoabdominal aortic pathology remains ill defined. We
have found that there are significant advantages to a hybrid
approach in high-risk patients. Avoidance of a thoracotomy
for repair of the thoracic component of the pathology is a
significant benefit. The ability to stage the procedure in
Table IV. Reported series of a combined endovascular an
or more patients)
Author
(reference) Year Patients TAAA/arch
Mortal
30 da
Lee5 2005 17* 17/0 24%
Resch6 2006 13 13/0 23%
Black7 2006 22 22/0 13%
Zhou8 2006 31 15/16 3.2
Chiesa9 2007 13# 13/0 23%
Bockler10 2008 28 28/0 14.3
Quinones 2008 20 17/3 0
*All staged procedures.
#Seven patients with aortic dissection.
Cumulative survival.selected cases may reduce the overall morbidity.Patients who become unstable or experience hypoten-
sion during the debranching portion of the procedure may
be better off postponing the endovascular portion as a
second stage. This will allow the system to recover, and
normalize to the new flow pattern. The single case of
paraplegia in our series was a patient with extensive thora-
coabdominal aortic coverage performed in a single stage. In
retrospect, a two-stage approach may have avoided this
complication. An additional benefit of CESA may be re-
lated to limiting the visceral ischemia to one organ at that
time. Avoidance of high aortic cross-clamping, and global
visceral ischemia as is necessary during surgical repair, may
contribute to a lower incidence of paraplegia and organ
failure. In our series, there was no incidence of visceral
organ failure during either single or a two-stage procedure.
When patients are approached in two stages, placement
of a subcutaneous conduit to be used at the second stage
simplifies the approach. We now routinely place the con-
duit at the first stage, which allows insertion of the endo-
vascular graft with a simple cutdown. It is important to
place the distal end of the conduit in a way that will not
interfere with visceral flow during introduction of the en-
dovascular graft. In addition, if the conduit is placed at the
hood of the origin graft for visceral revascularization, care
must be taken to observe sterile technique, as infection of
this conduit would lead to serious consequences. Alterna-
tively, the conduit may be placed in the contralateral com-
mon iliac artery, which would avoid this potential compli-
cations altogether. In a single stage approach, the conduit is
ligated flush to its origin.
Placement of a marker clip proximal to the origin of
visceral grafts, or distal to the origin of ascending aortic
grafts has proven helpful during the endovascular compo-
nent of the procedure. This will limit the amount of con-
trast needed, particularly in the single stage approach.
Retrograde visceral graft coverage is also a key component
of the hybrid approach. Care must be taken to avoid
contact with intestines to prevent the potential long-term
complications of graft enteric erosion. We routinely cover
these grafts with surrounding retroperitoneal tissue or in
some cases with an omental flap.
One of the potential drawbacks on the durability of a
gical approach to thoracoabdominal aortic pathology (10
Permanent
paraplegia
Overall
morbidity
Median follow up
(months) Survival
0 25% 8 100%
30% 46% NA NA
0 54% 8 NA
0 9.6% 16 90%
0 31% 14.9 76.9%
11% 59% 22 70%
6.6% 32% 16.6 76%d sur
ity
ys
%
%combined endovascular and surgical approachmay relate to
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Kansal and associates reported a retrospective review com-
paring antegrade and retrograde mesenteric bypasses.11
The combined experience of two major vascular centers
showed no difference in the long-term durability of these
two options. In fact, they noted a lower mortality for the
retrograde approach, probably related to the avoidance of
supraceliac aorta cross clamping. In a review of published
series of a combined endovascular and surgical approach for
thoracoabdominal aortic pathology, long-term graft pa-
tency has been reported between 86% and 100%.12 In our
own series, we have not seen any complication related to
the use of retrograde grafts for visceral revascularization, or
antegrade grafts for cerebrovascular revascularization.
Our experience with CESA for arch aneurysms is lim-
ited. The largest experience reported to date is from Zhou
and colleagues, with 16 patients having a hybrid approach
for repair of aneurysms that included the ascending aorta
and or aortic arch.8 In eight patients, the endograft was
placed in an antegrade fashion upon completion of the
cerebrovascular debranching. There were no deaths, neu-
rologic deficits, or significant morbidity associated with this
approach. An additional eight patients had their grafts
placed in a retrograde fashion as the aneurysms also involve
the thoracoabdominal aorta. We have found that antegrade
placement is better for aneurysms that involve landing the
proximal end of the endograft in the ascending aorta. This
is particularly important in patients with unfavorable cur-
vature of the aortic arch. Using a conduit placed at the
hood of the origin of the extra-anatomic bypasses, and a
marker clip just distal to this origin, the endograft can be
introduced and deployed with minimal contrast.
Patients presenting with chronic aortic dissection
present particular challenges. We have found transesopha-
geal echocardiography (TEE) very useful during the endo-
vascular component of the repair. This helps identify the
location of the guide wire in the true or false lumen so that
appropriate deployment can be performed. An experienced
anesthesiologist with TEE is important in the interpreta-
tion of the images. Intravascular ultrasound can also be
used for this purpose. One of the advantages of TEE is that
none of the access sites is used as it is when using intravas-
cular ultrasound. No exchanges are necessary and therefore
real-time views of the procedure and deployment are pos-
sible. In one of our cases, the endovascular graft was
purposely deployed in the false lumen to allow maximum
expansion of the endograft. This was a patient with a prior
interposition graft in the proximal descending thoracic
aorta, and an infrarenal aortic graft placed at the first stage
of the procedure. The endovascular repair at the second
stage had the proximal landing zone in the previously
placed thoracic interposition graft and distally, in the re-
cently placed infrarenal graft. In most instances, however,
deployment in the true lumen is mandatory.
The mid- and long-term results in our experience with
CESA have been encouraging, recognizing that most of the
patients have relatively short follow-up. Overall survival at
two years by cumulative methods in patients completingthe procedure was 76%. This compares well with survival
after surgical repair.13,14 Importantly, there has been no
aneurysm-related death, and graft patency has not been an
issue. Our longest survivor has been followed for 10 years
with no aneurysm growth or procedure related complica-
tion (Fig 3). This suggests that a combined endovascular
and surgical approach to thoracoabdominal aortic pathol-
ogy can be durable. All deaths have occurred within six
months of the procedure. One patient died from aneurysm
rupture after refusing to undergo the second stage of the
procedure. It is imperative that patients, in whom a two-
stage approach is planned, are informed that the first stage
of the procedure is a major surgical intervention and can
expect a much easier recovery after the second stage. Three
of the four deaths occurred in patients that had major
complications following the procedure. Two of these pa-
tients had history of congestive heart failure (two) and
renal insufficiency (one), and the third had severe chronic
obstructive pulmonary disease (COPD) and was oxygen-
dependent. One could question the judgment of proceed-
ing with any type of repair in patients with such comorbidi-
ties. The reality is that, faced with an individual patient, this
is an extremely difficult decision to make. The last patient
died of unknown causes but the history surrounding the
death suggests that it was not aneurysm or procedure
Fig 3. Computed tomography (CT) scan with three-dimensional
reconstruction 10 years after endovascular and surgical repair of a
type IV thoracoabdominal aneurysm performed in 1998 and re-
ported in 1999 (see text).related.
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approach to thoracoabdominal aortic pathology can be
performed with acceptable results in high-risk patients. We
prefer a two-stage approach for patients that require exten-
sive aortic coverage, or who become unstable during the
debranching stage of the procedure. In a two-stage ap-
proach, placement of a subcutaneous conduit and marker
clips facilitates the endovascular portion of the procedure.
Transesophageal echocardiography is a useful tool during
the endovascular component in patients with aortic dissec-
tion. Our experience to date suggests that the hybrid
approach can be a durable repair. Given the limited
follow-up available, however, younger patients with accept-
able risk should continue to be treated with conventional
surgery. Our results support the continued use of a com-
bined endovascular surgical approach to thoracoabdominal
aortic pathology in high-risk patients.
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